The page below is a sample from the LabCE course Immune Hemolytic Anemias. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Immune Hemolytic Anemias (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 94 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Treatment of Drug-Induced Immune Hemolytic Anemia

In patients with drug-induced hemolytic anemia, the preferred treatment is discontinuation of the drug. Other drugs may be substituted.
A positive DAT does not indicate that drug therapy should be stopped, especially if the drug is therapeutically beneficial and significant hemolysis is not present. If hemolytic anemia is not present, continuation of drug therapy is an option.